439 filings
SD
HBIO
Harvard Bioscience Inc.
29 May 24
Conflict minerals disclosure
5:01pm
8-K
HBIO
Harvard Bioscience Inc.
14 May 24
Submission of Matters to a Vote of Security Holders
5:20pm
10-Q
2024 Q1
HBIO
Harvard Bioscience Inc.
Quarterly report
7 May 24
5:00pm
8-K
HBIO
Harvard Bioscience Inc.
7 May 24
Harvard Bioscience Announces First Quarter 2024 Financial Results
7:00am
ARS
2023 FY
HBIO
Harvard Bioscience Inc.
3 Apr 24
Annual report to shareholders
4:51pm
DEFA14A
abc912
3 Apr 24
Additional proxy soliciting materials
4:46pm
8-K
n4iq9w187y z6f4i
3 Apr 24
Entry into a Material Definitive Agreement
8:01am
8-K
q4l529qee9c ec
26 Mar 24
Departure of Directors or Certain Officers
5:00pm
8-K
e2uenhw vo
7 Mar 24
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
7:00am
8-K
0hat9
5 Jan 24
Results of Operations and Financial Condition
5:01pm
8-K
cbvun5gnzpx8
7 Nov 23
Harvard Bioscience Announces Third Quarter 2023 Financial Results
7:00am
UPLOAD
aq6 q1p4s
16 Aug 23
Letter from SEC
12:00am
CORRESP
6nc p4xjf7i8
9 Aug 23
Correspondence with SEC
12:00am
8-K
yv8i2lf5
8 Aug 23
Harvard Bioscience Announces Second Quarter 2023 Financial Results
9:05am
UPLOAD
kw71477962 9slqz1x
28 Jul 23
Letter from SEC
12:00am
8-K
jg8t7sw1nw3
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am